Abstract
The ongoing novel coronavirus pandemic caused by the SARS-COV-2 virus has severely affected the global population. As various vaccines are being introduced to combat this virus, several adverse effects are being commonly reported such as mucocutaneous reactions, local injection site reactions, and delayed hypersensitivity reactions manifesting as “COVID arm.” However, uncommon side effects like reactivation of certain viruses are also being recently reported. We are reporting three cases of herpes zoster which occurred following the first dose of the recombinant COVID-19 AZD1222 vaccine, to generate awareness about this uncommon sequel.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
